1 | 1849124 | A lack of detectable modification of topoisomerase II activity in a series of human tumor cell lines expressing only low levels of etoposide resistance. | Int J Cancer | 1991 Apr 1 |
1 |
2 | 2643296 | A comparative study of doxorubicin and epirubicin in patients with metastatic breast cancer. | Am J Clin Oncol | 1989 Feb |
1 |
3 | 3495512 | Effects of fractionated X-irradiation on subsequent response to acute X-irradiation in two human tumour cell lines in vitro. | Int J Radiat Biol Relat Stud Phys Chem Med | 1987 Apr |
1 |
4 | 3501539 | Comparison of unique leucovorin and 5-fluorouracil "escalating" and "maximum" dosage strategies. | NCI Monogr | 1987 |
2 |
5 | 8555803 | Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom. | BMJ | 1995 Dec 16 |
1 |
6 | 9621488 | Platinum compounds as radiosensitizers in strontium-89 metabolic radiotherapy. | Clin Ter | 1998 Jan-Feb |
1 |
7 | 10457448 | Detection of the chemical warfare agents bis-(2-chloroethyl)ethylamine (HN-1) and tris-(2-chloroethyl)amine (HN-3) in air. | J Chromatogr A | 1999 Jul 23 |
1 |
8 | 11180637 | Identification of the nitrogen-based blister agents bis(2-chloroethyl)methylamine (HN-2) and tris(2-chloroethyl)amine (HN-3) and their hydrolysis products on soil using ion trap secondary ion mass spectrometry. | J Mass Spectrom | 2000 Dec |
6 |
9 | 11298943 | Anti-proliferative effect of two lactic acid bacteria strains of human origin on the growth of a myeloma cell line. | Lett Appl Microbiol | 2001 Apr |
1 |
10 | 11786584 | 13-cis retinoic acid and complete androgen blockade in advanced hormone-naive prostate cancer patients: report of a phase II randomized study. | J Clin Oncol | 2002 Jan 15 |
1 |
11 | 14669291 | A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas. | Cancer | 2003 Dec 15 |
1 |
12 | 15094197 | Cloning, expression and subcellular localization of HN1 and HN1L genes, as well as characterization of their orthologs, defining an evolutionarily conserved gene family. | Gene | 2004 Apr 28 |
1 |
13 | 15239850 | Quantitation of biomarkers of exposure to nitrogen mustards in urine from rats dosed with nitrogen mustards and from an unexposed human population. | J Anal Toxicol | 2004 Jul-Aug |
2 |
14 | 15248900 | Beckman Access versus the Bayer ACS:180 and the Abbott AxSYM cardiac Troponin-I real-time immunoassays: an observational prospective study. | BMC Emerg Med | 2004 Jul 13 |
1 |
15 | 17117222 | Evidence for intramolecular aromatic-ring stacking in the physiological pH range of the monodeprotonated xanthine residue in mixed-ligand complexes containing xanthosinate 5'-monophosphate (XMP). | Dalton Trans | 2006 Dec 14 |
8 |
16 | 17290061 | Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. | J Clin Oncol | 2007 Feb 10 |
1 |
17 | 17596709 | Novel processing of Notch 1 within its intracellular domain by a cysteine protease. | Neurodegener Dis | 2007 |
4 |
18 | 18269793 | Development of a liquid chromatography-multiple reaction monitoring procedure for concurrent verification of exposure to different forms of mustard agents. | J Anal Toxicol | 2008 Jan-Feb |
1 |
19 | 18674684 | A treatment planning investigation into the dosimetric effects of systematic prostate patient rotational set-up errors. | Med Dosim | 2008 Autumn |
1 |
20 | 20814829 | Targeting head and neck squamous cell carcinoma using a novel fusion toxin-diphtheria toxin/HN-1. | Mol Biol Rep | 2011 Feb |
1 |
21 | 21323578 | Ubiquitously expressed hematological and neurological expressed 1 downregulates Akt-mediated GSK3β signaling, and its knockdown results in deregulated G2/M transition in prostate cells. | DNA Cell Biol | 2011 Jun |
2 |
22 | 21665250 | Consolidation paclitaxel is more cost-effective than bevacizumab following upfront treatment of advanced epithelial ovarian cancer. | Gynecol Oncol | 2011 Sep |
1 |
23 | 21764395 | High-throughput sample preparation and simultaneous column regeneration liquid chromatography-tandem mass spectrometry method for determination of nitrogen mustard metabolites in human urine. | J Chromatogr B Analyt Technol Biomed Life Sci | 2011 Aug 15 |
5 |
24 | 22155408 | Androgen regulated HN1 leads proteosomal degradation of androgen receptor (AR) and negatively influences AR mediated transactivation in prostate cells. | Mol Cell Endocrinol | 2012 Mar 5 |
2 |
25 | 23443238 | Unexpected results in a randomized dietary trial to reduce phthalate and bisphenol A exposures. | J Expo Sci Environ Epidemiol | 2013 Jul |
2 |
26 | 23475103 | Phase II randomized trial of carboplatin and gemcitabine with or without dexamethasone pre-treatment in patients with Stage IV non-small cell lung cancer. | Cancer Chemother Pharmacol | 2013 May |
2 |
27 | 23589214 | Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors. | Invest New Drugs | 2014 Feb |
1 |
28 | 23747051 | Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: results of a randomised Phase 2 study. | Eur J Cancer | 2013 Sep |
4 |
29 | 24803430 | Fringe-mediated extension of O-linked fucose in the ligand-binding region of Notch1 increases binding to mammalian Notch ligands. | Proc Natl Acad Sci U S A | 2014 May 20 |
7 |
30 | 24837597 | Feasibility of cisplatin/5-fluorouracil and panitumumab in Japanese patients with squamous cell carcinoma of the head and neck. | Jpn J Clin Oncol | 2014 Jul |
1 |
31 | 24885354 | Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized trial. | BMC Cancer | 2014 May 20 |
1 |
32 | 25503468 | (1)H, (13)C and (15)N assignments of EGF domains 4 to 7 of human Notch-1. | Biomol NMR Assign | 2015 Oct |
1 |
33 | 25574925 | Tuberculosis patients learning about second-hand smoke (TBLASS): results of a pilot randomised controlled trial. | Int J Tuberc Lung Dis | 2015 Feb |
1 |
34 | 25644442 | Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian cancer in patients 65 years old or older. | Am J Obstet Gynecol | 2015 Jun |
1 |
35 | 25707487 | Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND Study. | Am J Transplant | 2015 Jul |
1 |
36 | 27139598 | Electron interaction with a DNA duplex: dCpdC:dGpdG. | Phys Chem Chem Phys | 2016 May 21 |
4 |
37 | 28002342 | Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study. | Medicine (Baltimore) | 2016 Dec |
1 |
38 | 28412450 | PEGylated doxorubicin nanoparticles mediated by HN-1 peptide for targeted treatment of oral squamous cell carcinoma. | Int J Pharm | 2017 Jun 15 |
4 |
39 | 29438199 | Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individuals. | AIDS | 2018 May 15 |
2 |
40 | 29442239 | Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers. | Support Care Cancer | 2018 Jul |
1 |
41 | 30616471 | Comparison of quality of life of patients on treatment with cisplatin and gemcitabine, carboplatin and gemcitabine, carboplatin and paclitaxel, carboplatin and pemetrexed for non-small cell lung cancer. | J Oncol Pharm Pract | 2019 Dec |
3 |
42 | 31119765 | Closer: A videoconference intervention for distance caregivers of cancer patients. | Res Nurs Health | 2019 Aug |
1 |
43 | 31581474 | Structural Basis for the Regulation of PPARγ Activity by Imatinib. | Molecules | 2019 Oct 1 |
1 |
44 | 32700728 | HN1 as a diagnostic and prognostic biomarker for liver cancer. | Biosci Rep | 2020 Jul 31 |
1 |
45 | 33462277 | Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy. | Sci Rep | 2021 Jan 18 |
5 |
46 | 33683482 | nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial. | Med Oncol | 2021 Mar 8 |
2 |
47 | 33685502 | Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial. | Trials | 2021 Mar 8 |
2 |
48 | 34319586 | A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors. | Int J Cancer | 2021 Dec 15 |
1 |
49 | 34969250 | In Vitro Evaluation of DNA Damage Effect Markers toward Five Nitrogen Mustards Based on Liquid Chromatography-Tandem Mass Spectrometry. | Chem Res Toxicol | 2022 Jan 17 |
10 |